Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Actavis Completes Acquisition of Allergan

March 18, 2015 9:09 am | News | Comments

The deal is valued at approximately $70.5 billion. Read more...

TOPICS:

Potential Drug Target Found to Prevent Bowel Cancer Spread

March 18, 2015 9:03 am | by Monash University | News | Comments

Scientists have discovered a molecule that is crucial to the survival of stem cells in the intestine. Read more...

TOPICS:

Roche Launches Next-Generation Duplex Test for Parovirus B19, Hepatitis A

March 18, 2015 8:56 am | News | Comments

This test is only available in markets accepting the CE mark. Read more...

TOPICS:
Advertisement

Emerging Diseases Likely to be More Harmful in Similar Species

March 18, 2015 8:49 am | by University of Cambridge | News | Comments

Research shows that it may be possible to predict the virulence of a virus by looking at how deadly it is in closely-related species. Read more...

TOPICS:

New Hope for Kidney Disease

March 18, 2015 8:43 am | by Monash University | News | Comments

Researchers have made a discovery that could see patients with kidney disease no longer having to resort to dialysis or kidney transplants. Read more...

TOPICS:

Study: Euthanasia Cases More Than Double in Northern Belgium

March 18, 2015 8:40 am | by Raf Casert, Associated Press | News | Comments

Almost one in 20 people in northern Belgium died using euthanasia in 2013, more than doubling the numbers in six years. Read more...

TOPICS:

Prices of Cancer Drugs Have Soared Since 1995: Study

March 17, 2015 12:43 pm | by Peter Dizikes, MIT News | News | Comments

The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist — but the exact reasons for the cost increases are unclear. Read more...

TOPICS:

U.S. Pharmaceutical Market Value Will Approach $550 Billion by 2020: GlobalData

March 17, 2015 12:31 pm | News | Comments

The U.S. pharmaceutical market is forecast to increase from an estimated value of $395.2 billion in 2014 to reach $548.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.6 percent, according to research and consulting firm GlobalData. Read more..

TOPICS:
Advertisement

Mississippi Wants Execution-Drug Supplier's Name Kept Secret

March 17, 2015 12:25 pm | by Jeff Amy - Associated Press | News | Comments

Mississippi's attorney general is asking a judge to keep the identity of the state's execution-drug supplier secret while he appeals her order to release the name. Read more....

TOPICS:

23andMe FDA Approval Clears Way for More Sequencing-Based Tests

March 17, 2015 12:17 pm | News | Comments

​Kalorama information suggests that the FDA approval of a rare gene test from Mountain View, Calif.-based personal genetics company 23andMe will open the way for more genetic tests sold to consumers or prescribed by doctors that use next-generation sequencing technology. Read more...

TOPICS:

Potential Treatment for Most Common Form of Muscular Dystrophy

March 17, 2015 12:02 pm | by University of Virginia Health System | News | Comments

A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could slow progression of muscle damage and muscle dysfunction associated with the disease – issues that cause patients significant disability and deterioration in quality of life. Read more...

TOPICS:

Gene Discovery Provides Clue to How TB May Evade the Immune System

March 17, 2015 9:01 am | by University of Cambridge | News | Comments

The largest genetic study of tuberculosis susceptibility to date has led to a potentially important new insight into how the pathogen manages to evade the immune system. Read more...

TOPICS:

New System Made for Detecting Adverse Effects of Medications Using Social Media

March 17, 2015 8:55 am | by Universidad Carlos III de Madrid | News | Comments

Researchers have developed a system for detecting adverse effects of pharmaceutical drugs by tracking information generated by patients on specialized blogs or social networks such as Twitter in real time. Read more...

TOPICS:

GSK Announces Start of Phase 3 Program for Retosiban Evaluation

March 17, 2015 8:46 am | News | Comments

Retosiban is an investigational oxytocin antagonist. Read more...

TOPICS:

American Who Contracted Ebola Now in Critical Condition

March 17, 2015 8:41 am | by Brett Zongker, Associated Press | News | Comments

An American health care worker who contracted Ebola while volunteering in a Sierra Leone treatment unit has been downgraded to critical condition at the National Institutes of Health, doctors said Monday. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading